Abstract PO5-01-02: A Retrospective Review of Pathological Complete Response and Toxicity Rates to a Modified Version of TCHP (paclitaxel, Trastuzumab, Pertuzumab, Carboplatin) for HER2 Positive Breast Cancer Stage II and III
Cancer Research(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要